Dr. Reddy’s maintains strict compliance in 2024

Dr. Reddy’s Laboratories (RDY) has released an update.

Dr. company Reddy’s Laboratories Limited successfully complied with statutory compliance and good corporate practice regulations during the financial year ending March 31, 2024, as confirmed by a company secretarial audit. The company has maintained compliance with all relevant provisions of the SEBI Act, SCRA and various other SEBI regulations without reporting any deviations. This compliance report confirms Dr. Reddy’s commitment to regulatory compliance and transparency with stakeholders in the financial markets.

You can find more information about RDY stock on TipRanks Stock analysis page.